Task: Answer the MCQ question.
Question: Which drug exhibits a -2.814% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a: Cc1cc2c(SCC(=O)NC3CCCCC3)ncnc2s1
b: CCN(CC)CCCn1c2c(c(SCC(=O)Nc3cc(OC)cc(OC)c3)nc1=O)CCC2
c: CCCCN(C(=O)c1ccc(N2CCCC2=O)cc1)c1c(N)n(CCCC)c(=O)[nH]c1=O
Answer: a. Cc1cc2c(SCC(=O)NC3CCCCC3)ncnc2s1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1cc2c(SCC(=O)NC3CCCCC3)ncnc2s1
Cc1cc2c(SCC(=O)NC3CCCCC3)ncnc2s1
N-cyclohexyl-2-(6-methylthieno[2,3-d]pyrimidin-4-yl)sulfanylacetamide